Clinical Trial Update: Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nivolumab in patients with advanced cutaneous squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Advanced Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN